Here are the Form 4 insider transactions from Park Ha Biological Technology Co., Ltd. (BYAH) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BYAH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BYAH filings page.
Zhu Xiaoyan reported acquisition or exercise transactions in this Form 4 filing.
Park Ha Biological Technology Co., Ltd. reported that CFO Zhu Xiaoyan received a grant of 112,500 Class A Ordinary Shares on August 3, 2026 at $0.18 per share, purchased from the company under its 2026 Share Incentive Plan. Following this award, she directly holds 112,500 shares. The reported share amounts reflect a 1-for-8 reverse stock split effective August 6, 2026.